Cranbrook Wealth Management’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-39
| Closed | -$10.9K | – | 394 |
|
|
2025
Q2 | $10.9K | Buy |
+39
| New | +$11K | ﹤0.01% | 290 |
|
|
2022
Q1 | – | Sell |
-147
| Closed | -$33K | – | 344 |
|
|
2021
Q4 | $33K | Sell |
147
-123
| -46% | -$26K | 0.01% | 209 |
|
|
2021
Q3 | $57K | Buy |
270
+25
| +10% | +$5.75K | 0.01% | 173 |
|
|
2021
Q2 | $60K | Sell |
245
-68
| -22% | -$16.7K | 0.01% | 162 |
|
|
2021
Q1 | $78K | Buy |
313
+68
| +28% | +$16.2K | 0.02% | 148 |
|
|
2020
Q4 | $56K | Hold |
245
| – | – | 0.01% | 152 |
|
|
2020
Q3 | $62K | Hold |
245
| – | – | 0.02% | 132 |
|
|
2020
Q2 | $58K | Hold |
245
| – | – | 0.02% | 130 |
|
|
2020
Q1 | $50K | Hold |
245
| – | – | 0.02% | 133 |
|
|
2019
Q4 | $59K | Hold |
245
| – | – | 0.02% | 136 |
|
|
2019
Q3 | $47K | Hold |
245
| – | – | 0.01% | 137 |
|
|
2019
Q2 | $45K | Hold |
245
| – | – | 0.01% | 134 |
|
|
2019
Q1 | $47K | Hold |
245
| – | – | 0.01% | 131 |
|
|
2018
Q4 | $48K | Hold |
245
| – | – | 0.02% | 122 |
|
|
2018
Q3 | $51K | Hold |
245
| – | – | 0.02% | 118 |
|
|
2018
Q2 | $45K | Hold |
245
| – | – | 0.02% | 122 |
|
|
2018
Q1 | $42K | Hold |
245
| – | – | 0.02% | 125 |
|
|
2017
Q4 | $43K | Buy |
245
+45
| +23% | +$7.96K | 0.02% | 127 |
|
|
2017
Q3 | $37K | Hold |
200
| – | – | 0.02% | 130 |
|
|
2017
Q2 | $34K | Hold |
200
| – | – | 0.01% | 138 |
|
|
2017
Q1 | $33K | Hold |
200
| – | – | 0.02% | 125 |
|
|
2016
Q4 | $29K | Buy |
200
+100
| +100% | +$15.1K | 0.01% | 137 |
|
|
2016
Q3 | $17K | Buy |
+100
| New | +$16.9K | 0.01% | 141 |
|
|
2016
Q2 | – | Sell |
-100
| Closed | -$15K | – | 194 |
|
|
2016
Q1 | $15K | Hold |
100
| – | – | 0.01% | 141 |
|
|
2015
Q4 | $16K | Hold |
100
| – | – | 0.01% | 141 |
|
|
2015
Q3 | $14K | Hold |
100
| – | – | 0.01% | 144 |
|
|
2015
Q2 | $15K | Hold |
100
| – | – | 0.01% | 155 |
|
|
2015
Q1 | $16K | Hold |
100
| – | – | 0.01% | 151 |
|
|
2014
Q4 | $16K | Buy |
+100
| New | +$15.6K | 0.01% | 148 |
|
|
2014
Q1 | – | Sell |
-37
| Closed | – | – | 153 |
|
|
2013
Q4 | $0 | Buy |
+37
| New | +$4.21K | ﹤0.01% | 221 |
|
Other funds holding AMGN
Cranbrook Wealth Management's AMGN Position: Q3 2025 in Review
Cranbrook Wealth Management sold out of Amgen (AMGN) in Q3 2025, closing a stake of 39 shares — an estimated $10.9K sold.
Cranbrook Wealth Management first reported a position in AMGN in Q4 2013 and held it in 30 quarters. The position peaked at $78K in Q1 2021. 2,819 funds tracked by Wall St. Rank hold AMGN as of Q3 2025.
- Cranbrook Wealth Management reported no remaining Amgen position as of Q3 2025 after selling out during the quarter.
- Cranbrook Wealth Management sold 39 Amgen shares in Q3 2025, an estimated $10.9K.
- Cranbrook Wealth Management first reported a position in Amgen in Q4 2013 and held it in 30 quarters.
- Cranbrook Wealth Management's Amgen position peaked at $78K in Q1 2021.
- 2,819 funds tracked by Wall St. Rank held Amgen as of Q3 2025.
Based on Cranbrook Wealth Management's 13F filing for Q3 2025, filed 14 Oct 2025.